Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
Trends in Pharmacological Sciences
|
April 16, 2013
Challenges and opportunities of drug repositioning
Natalia Novac
Current Drug Targets. Inflammation and Allergy
|
December 9, 2004
Nuclear receptors: overview and classification
Natalia Novac, Thorsten Heinzel
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
June 14, 2006
Competition between glucocorticoid receptor and NFkappaB for control of the human FasL promoter
Natalia Novac, Daniela Baus, Anja Dostert, et al.
Drug Discovery Today
|
January 3, 2013
Challenges and opportunities for oncology biomarker discovery
Avisek Deyati, Erfan Younesi, Martin Hofmann-Apitius, et al.
Scientific Reports
|
January 28, 2015
Systems approach for the selection of micro-RNAs as therapeutic biomarkers of anti-EGFR monoclonal antibody treatment in colorectal cancer
Avisek Deyati, Shweta Bagewadi, Philipp Senger, et al.
Molecular Biology of the Cell
|
January 20, 2006
SUMOylation of the corepressor N-CoR modulates its capacity to repress transcription
Jens Tiefenbach, Natalia Novac, Miryam Ducasse, et al.
Personalized Medicine
|
May 23, 2018
Molecular biomarkers in clinical development: what could we learn from the clinical trial registry?
Avisek Deyati, Rama Devi Sanam, Sreenivasa Rao Guggilla, et al.
BMC Medical Informatics and Decision Making
|
December 20, 2012
Mining biomarker information in biomedical literature
Erfan Younesi, Luca Toldo, Bernd Müller, et al.
Blood
|
April 2, 2005
Glucocorticoids inhibit activation-induced cell death (AICD) via direct DNA-dependent repression of the CD95 ligand gene by a glucocorticoid receptor dimer
Sven Baumann, Anja Dostert, Natalia Novac, et al.
The Journal of Pathology
|
July 12, 2011
Discovery of a novel tumour metastasis-promoting gene, NVM-1
Wilko Thiele, Natalia Novac, Sigrun Mink, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
Trends in Pharmacological Sciences
|
April 16, 2013
Challenges and opportunities of drug repositioning
Natalia Novac
Current Drug Targets. Inflammation and Allergy
|
December 9, 2004
Nuclear receptors: overview and classification
Natalia Novac, Thorsten Heinzel
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
June 14, 2006
Competition between glucocorticoid receptor and NFkappaB for control of the human FasL promoter
Natalia Novac, Daniela Baus, Anja Dostert, et al.
Drug Discovery Today
|
January 3, 2013
Challenges and opportunities for oncology biomarker discovery
Avisek Deyati, Erfan Younesi, Martin Hofmann-Apitius, et al.
Scientific Reports
|
January 28, 2015
Systems approach for the selection of micro-RNAs as therapeutic biomarkers of anti-EGFR monoclonal antibody treatment in colorectal cancer
Avisek Deyati, Shweta Bagewadi, Philipp Senger, et al.
Molecular Biology of the Cell
|
January 20, 2006
SUMOylation of the corepressor N-CoR modulates its capacity to repress transcription
Jens Tiefenbach, Natalia Novac, Miryam Ducasse, et al.
Personalized Medicine
|
May 23, 2018
Molecular biomarkers in clinical development: what could we learn from the clinical trial registry?
Avisek Deyati, Rama Devi Sanam, Sreenivasa Rao Guggilla, et al.
BMC Medical Informatics and Decision Making
|
December 20, 2012
Mining biomarker information in biomedical literature
Erfan Younesi, Luca Toldo, Bernd Müller, et al.
Blood
|
April 2, 2005
Glucocorticoids inhibit activation-induced cell death (AICD) via direct DNA-dependent repression of the CD95 ligand gene by a glucocorticoid receptor dimer
Sven Baumann, Anja Dostert, Natalia Novac, et al.
The Journal of Pathology
|
July 12, 2011
Discovery of a novel tumour metastasis-promoting gene, NVM-1
Wilko Thiele, Natalia Novac, Sigrun Mink, et al.
Page
of 1